Eden Rahim, Portfolio Manager and Options Strategist at Next Edge Capital joins BNN to discuss the current state of the biotech industry. He says that Canada's healthcare market has been "bifurcated" this year, with big pharma companies like Valeant and Concordia "hogging the headlines" and innovative small-cap companies rallying to new highs.